RUNX transcription factors as key targets of TGF-β superfamily signaling

Current Opinion in Genetics and Development

Volumn 13, Issue 1, 2003, Pages 43-47

  Ito, Yoshiaki ^a   Miyazono, Kohei ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; PROTEIN; SMAD PROTEIN; SMAD1 PROTEIN; SMAD2 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RUNX; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR RUNX3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANGIOGENESIS; BIOLOGY; BONE DEVELOPMENT; HEMATOPOIESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; REVIEW; STOMACH CANCER; TUMOR SUPPRESSOR GENE;

EID: 0037310863     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(03)00007-8     Document Type: Review

References (43)

1. Miyazono K., Kusanagi K., Inoue H. Divergence and convergence of TGF-β/BMP signaling. J. Cell Physiol. 187:2001;265-276.
2. Miyazawa K., Shinozaki M., Hara T., Furuya T., Miyazono K. Two major Smad pathways in TGF-β superfamily signaling. Genes Cells. 7:2002;1191-1204.
3. Hanai J., Chen L.F., Kanno T., Ohtani-Fujita N., Kim W.-Y., Guo W.-H., Imamura T., Ishidou Y., Fukuchi M., Shi M.-J.et al. Interaction and functional cooperation of PEBP2/CBF with Smads: synergistic induction of the immunoglobulin germline Cα promoter. J. Biol. Chem. 274:1999;31577-31582.
4. -/- mice show hyperplasia in the glandular stomach epithelial cells, which appears to be due to insensitivity of the cells to the growth-inhibitory activity and the apoptosis-inducing activity of TGF-β. As RUNX proteins are integral components of the TGF-β signaling cascade, the authors suggest that RUNX3 is a new addition to the TGF-β-induced tumor suppressor pathway.
5. Weith A., Brodeur G.M., Bruns G.A., Matise T.C., Mischke D., Nizetic D., Seldin M.F., van Roy N., Vance J. Report of the second international workshop on human chromosome 1 mapping 1995. Cytogenet Cell Genet. 72:1995;114-144.
6. Ito Y. Molecular basis of tissue-specific gene expression mediated by the Runt domain transcription factor, PEBP2/CBF. Genes Cells. 4:1999;685-696.
7. Huang G., Shigesada K., Ito K., Wee H.-J., Yokomizo T., Ito Y. Dimerization with PEBP2β protects RUNX1/AML1 from ubiquitin-proteasome-mediated degradation. EMBO J. 20:2001;723-733.
8. Zhang Y.-W., Yasui N., Ito K., Huang G., Fujii M., Hanai J., Nogami H., Ochi T., Miyazono K., Ito Y. A RUNX2/PEBP2αA/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia. Proc. Natl. Acad. Sci. U.S.A. 97:2000;10549-10554 This paper is the first to show that the BMP-induced osteogenic signaling pathway is mediated by RUNX2/CBFA1. Mutated RUNX2 cannot transmit the BMP signal to downstream targets and this defect appears to be the cause of cleidocranial dysplasia.
9. Alliston T., Choy L., Ducy P., Karsenty G., Derynck R. TGF-β-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation. EMBO J. 20:2001;2254-2272 The authors describe the mechanism of inhibition of osteoblastic differentiation by TGF-β. This meticulously performed study shows, among other things, the ligand-dependent interaction of RUNX2/CBFA1 and Smad3 and their synergistic action to inhibit the osteocalcin promoter.
10. Pardali E., Xie X.Q., Tsapogas P., Itoh S., Arvanitidis K., Heldin C.H., ten Dijke P., Grundstrom T., Sideras P. Smad and AML proteins synergistically confer transforming growth factor β1 responsiveness to human germ-line IgA genes. J. Biol. Chem. 275:2000;3552-3560.
11. Zhang Y., Derynck R. Transcriptional regulation of the transforming growth factor-beta-inducible mouse germ line Ig alpha constant region by functional cooperation of Smad, CREB, and AML family members. J. Biol. Chem. 275:2000;16979-16985.
12. Inoue K., Ozaki S., Shiga T., Ito K., Masuda T., Okado N., Iseda T., Kawaguchi S., Ogawa M., Bae S.-C.et al. Runx3 controls the axonal projection of proprioceptive dorsal root ganglion neurons. Nat. Neurosci. 5:2002;946-954 The authors describe how Runx3 controls the target specific pathfinding of proprioceptive DRG neurons in the spinal cord. Although proprioceptive ganglion neurons do not reach central and peripheral targets, they do not seem to undergo apoptosis unexpectedly. As TGF-β is considered to regulate ontogenetic neuron death, Runx3 might be involved in this process. Because neuroblastoma cells and DRG neurons originate from neural crest, the results obtained by this study might contribute to the study of neuroblastoma, especially in the light of [26].
13. Taniuchi I., Osato M., Egawa T., Sunshine M.J., Bae S.-C., Komori T., Ito Y., Littman D.R. Requirement for Runx proteins in CD4 silencing at different stages of T lymphocyte development. Cell. 111:2002;621-633.
14. Nam S., Jin Y.-H., Li Q.-L., Lee K.-Y., Jeong G.-B., Ito Y., Lee J., Bae S.-C. Expression pattern, regulation, and biological role of Runt domain transcription factor, run, in Caenorhabditis elegans. Mol. Cell Biol. 22:2002;547-554.
15. Massague J., Blain S.W., Lo R.S. TGFβ signaling in growth control, cancer, and heritable disorders. Cell. 103:2000;295-309.
16. Derynck R., Akhurst R.J., Balmain A.S. TGF-β signaling in tumor suppression and cancer progression. Nat. Genet. 9:2001;117-129.
17. Tang B., Bottinger E.P., Jakowlew S.B., Bagnall K.M., Mariano J., Anver M.R., Letterio J.J., Wakefield L.M. Transforming growth factor-beta1 is a new form of tumor suppressor with true haploid insufficiency. Nat. Med. 4:1998;802-807.
18. Shull M.M., Ormsby I., Kier A.B., Pawlowski S., Diebold R.J., Yin M., Allen R., Sidman C., Proetzel G., Calvin D.et al. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature. 359:1992;693-699.
19. Muraoka M., Konishi M., Kikuchi-Yonoshita R., Tanaka K., Shitara N., Chong J.M., Iwama T., Miyaki M. p300 gene alterations in colorectal and gastric carcinomas. Oncogene. 12:1996;1565-1569.
20. Gayther S.A., Batley S.J., Linger L., Bannister A., Thorpe K., Chin S.F., Daigo Y., Russell P., Wilson A., Sowter H.M.et al. Mutations truncating the EP300 acetylase in human cancers. Nat. Genet. 24:2000;300-303.
21. Suganuma T., Kawabata M., Ohshima T., Ikeda M. Growth suppression of human carcinoma cells by reintroduction of the p300 coactivator. Proc. Natl. Acad. Sci. U.S.A. 99:2002;13073-13078 The transcriptional coactivator p300 is targeted by viral oncoprotein and is suggested to be a tumor suppressor. The transcriptional response to TGF-β was severely impaired in the cancer cells that contain mutations in the p300 gene accompanied by the inactivation of the second allele. They show that Smad signaling and p300, but not the mutant forms identified in cancer cells, synergistically activate the p21 gene promoter, suggesting that the growth-suppressive effect of TGF-β may be mediated by this mechanism.
22. Kitabayashi I., Yokoyama A., Shimizu K., Ohki M. Interaction and functional cooperation of the leukemia-associated factors AML1 and p300 in myeloid cell differentiation. EMBO J. 17:1998;2994-3004.
23. Lutterbach B., Westendorf J.J., Linggi B., Isaac S., Seto E., Hiebert S.W. A mechanism of repression by acute myeloid leukemia-1, the target of multiple chromosomal translocation in acute leukemia. J. Biol. Chem. 275:2000;651-655.
24. Levanon D., Bettoun D., Harris-Cerruti C., Woolf E., Negreanu V., Eilam R., Bernstein Y., Goldenberg D., Xiao C. The Runx3 transcription factor regulates development and survival of TrkC dorsal root ganglion neurons. EMBO J. 21:2002;3454-3463.
25. Krieglstein K., Richter S., Farkas L., Schuster N., Dunker N., Oppenheim R.W., Unsicker K. Reduction of endogenous transforming growth factors β prevents ontogenetic neuron death. Nat. Neurosci. 3:2000;1085-1090.
26. Spieker N., Beitsma M., Van Sluis P., Chan A., Caron H., Versteeg R. Three chromosomal rearrangements in neuroblastoma cluster within a 300-kb region on 1p36.1. Genes Chromosomes Cancer. 31:2001;172-181.
27. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., Shimizu Y., Branson R.T., Gao Y.H., Inada M., Sato M.et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell. 89:1997;755-764.
28. Otto F., Thornell A.P., Crompton T., Denzel A., Gilmour K.C., Rosewell I.R., Stamp G.W., Beddington R.S., Mundlos S., Olsen B.R.et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell. 89:1997;765-771.
29. Lee B., Thirunavukkarasu K., Zhou L., Pastore L., Baldini A., Hecht J., Geoffroy V., Ducy P., Karsenty G. Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia. Nat. Genet. 16:1997;307-310.
30. Mundlos S., Otto F., Mundlod C., Mulliken J.B., Aylsworth A.S., Albright S., Lindhout D., Cole W.G., Henn W., Knoll J.H.et al. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell. 89:1997;773-779.
31. Lee K.S., Kim H.J., Li Q.L., Chi X.Z., Ueta C., Komori T., Wozney J.M., Kim E.G., Choi J.Y., Ryoo H.M.et al. Runx2 is a common target of transforming growth factor β1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol. Cell Biol. 20:2000;8783-8792.
32. Okuda T., van Deursen J., Hiebert S.W., Grosveld G., Downing J.R. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell. 84:1996;321-330.
33. Wang Q., Stacy T., Binder M., Martin-Padilla M., Sharpe A.H., Speck N.A. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and block definitive hematopoiesis. Proc. Natl. Acad. Sci. U.S.A. 93:1996;3444-3449.
34. Speck N.A., Gilliland D.G. Core-binding factors in hematopoiesis and leukemia. Nat. Rev. Cancer. 2:2002;502-513.
35. Osato M., Asou N., Abdalla E., Hoshino K., Yamasaki H., Okubo T., Suzushima H., Takatsuki K., Kanno T., Shigesada K.et al. Biallelic and heterozygous point mutations in the Runt domain of the AML1/PEBP2αB gene associated with myeloblastic leukemias. Blood. 93:1999;1817-1824.
36. Song W.J., Sullivan M.G., Legare R.D., Hutchings S., Tan X., Kuffrin D., Ratajczak J., Resende I.C., Haworth C., Hock R.et al. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukemia. Nat. Genet. 23:1999;166-175.
37. Fortunel N.O., Hatzfeld A., Hatzfeld J.A. Transforming growth factor-β: pleiotropic role in the regulation of hematopoiesis. Blood. 96:2000;2022-2036.
38. North T., Gu T.L., Stacy T., Wang Q., Howard L., Binder M., Martin-Padilla M., Speck N.A. Cbfa2 is required for the formation of intra-aortic hematopoietic clusters. Development. 126:1999;2563-2575.
39. Yokomizo T., Ogawa M., Osato M., Kanno T., Yoshida H., Fujimoto T., Fraser S., Nishikawa S., Okada H., Satake M.et al. Requirement of Runx1/AML1/PEBP2αB for the generation of hematopoietc cells from endothelial cells. Genes Cells. 6:2001;13-23.
40. Marshall C.J., Kinnon C., Thrasher A.J. Polarized expression of bone morphogenetic protein-4 in the human aorta-gonad-mesonephros region. Blood. 96:2000;1591-1593.
41. Liu B, Sun Y, Zhang S, Wu Y, Lan Y, Yang X, Mao N: Disruption of Smad5 gene leads to enhanced proliferation of high proliferative potential precursors during embryonic hematopoiesis. Blood 2002, in press.
42. Takakura N., Watanabe T., Suenobu S., Yamada Y., Noda T., Ito Y., Satake M., Suda T. A role for hematopoietic stem cells in promoting angiogenesis. Cell. 102:2000;199-209 The authors describe the delicate interplay between endothelial cells and hematopoietic stem cells in angiogenesis. In Runx1-null mouse embryos, massive hemorrhage of primitive red blood cells is observed. The authors find that this is caused by incomplete angiogenesis itself, caused by a lack of hematopoietic stem cells that secrete angiopoietin-1, which is required for angiogenesis.
43. Dickson M.C., Martin J.S., Cousins F.M., Kulkarni A.B., Karlsson S., Akhurst R.J. Defective hematopoiesis and vasculogenesis in transforming growth factor-β1 knock out mice. Development. 121:1995;1845-1854.